leadf
logo-loader
viewImagin Medical
(
CSE:IMEOTCQB:IMEXF
)

Imagin Medical highlights the capabilities of its i/Blue Imaging System to detect bladder cancer

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) CEO Jim Hutchens tells Proactive he believes the surgical imaging company can increase the efficiency and accuracy of detecting cancer, specifically bladder cancer, with its i/Blue Imaging System.

Hutchens is hosting a virtual investor event with key opinion leaders to highlight the potential of the i/Blue™ Imaging System on Thursday, October 29, 2020 at 12:00 pm EST.

Quick facts: Imagin Medical

Follow
CSE:IME

Price: 0.58 CAD

Market Cap: $5.29 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

PyroGenesis Canada says it has received a $6M plasma torch order with major...

PyroGenesis Canada Inc CEO Peter Pascali tells Proactive the group has received an order to supply four high-powered plasma torches together with ancillary equipment to a client (Client B) for about $6 million. Pascali says Client B is a multi-billion-dollar international producer of iron...

1 hour, 25 minutes ago

2 min read